Supporting Treatment Adherence for Resilience and Thriving

Who is this study for? Patients with HIV
What treatments are being studied? START mHealth Intervention
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: No
View:

• Assigned male at birth;

• Identifies as male;

• Age 18 or older;

• reads and speaks English;

• Continental US residency;

• Reports any anal sex with a man in the past year;

• Currently has an active Antiretroviral Therapy (ART) prescription and reports less than excellent ART adherence (past 30 days);

• Screens positive for a moderate or severe stimulant use disorder with an abbreviated version of the National Institute on Drug Abuse (NIDA)-modified Alcohol, Smoking and Substance. Involvement Screening Test (ASSIST);

• Has an iPhone or Android smartphone;

• Is willing to participate in an mHealth intervention;

• Is willing to provide a Dried Blood Spot (DBS) specimen for viral load testing

Locations
United States
Florida
University of MIami
Recruiting
Miami
Contact Information
Primary
Adam W Carrico, PhD
a.carrico@miami.edu
305-243-6947
Time Frame
Start Date: June 15, 2022
Estimated Completion Date: May 1, 2024
Participants
Target number of participants: 350
Treatments
Experimental: START mHealth Intervention
Participants randomized to receive the START mHealth intervention will have access to the mHealth application for 6 months following randomization.
No Intervention: Website referrals
Participants in this condition will receive no intervention and will have access to a website with resources related to substance use disorder treatment and HIV treatment.
Authors
Adam W Carrico
Related Therapeutic Areas
Sponsors
Leads: University of Miami
Collaborators: National Institute on Drug Abuse (NIDA)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials